Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O95251
UPID:
KAT7_HUMAN
Alternative names:
Histone acetyltransferase binding to ORC1; Lysine acetyltransferase 7; MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2
Alternative UPACC:
O95251; B3KN74; B4DF85; B4DFB4; B4DFE0; B4DGY4; E7ER15; G5E9K7
Background:
Histone acetyltransferase KAT7, also known as Lysine acetyltransferase 7, plays a pivotal role in acetylating histone H3 at 'Lys-14' and histone H4 at multiple lysine residues. This acetylation is crucial for various biological processes including gene transcription, DNA replication initiation, and embryonic development. KAT7's specificity is modulated by its association with different scaffold subunits, directing its activity towards specific histone marks.
Therapeutic significance:
Understanding the role of Histone acetyltransferase KAT7 could open doors to potential therapeutic strategies. Its involvement in the maintenance of leukemia stem cells in acute myeloid leukemia (AML) by facilitating the expression of key genes highlights its potential as a target for therapeutic intervention in leukemia.